AXN|
Aoxing Pharmaceuticals | Profile | Summary
Aoxing
Pharmaceuticals (AXN) is a specialty pharmaceutical company engaged
in research, development, manufacturing and distribution of a variety
of narcotics and pain-management products.
Aoxing
was Founded in 1655, more than 300 years of heritage and deep roots
in traditional and contemporary Chinese medicine.
The
company has China's largest research & development facility (over
300 acre campus) and most advanced manufacturing facility for highly
regulated narcotic medicines. Over 500 employees are dedicated in
research and development of drugs for pain management, neurological
disorders and narcotics.
Its
facility is one of the few GMP facilities licensed for the
manufacture of highly regulated narcotic medicines by the China State
Food and Drug Administration (SFDA). It has strategic alliance
partnerships with global pharmaceutical companies like the UK's
Johnson Matthey Plc (LSE: JMAT), QRx Pharma (ASX: QRX) of Australia
and others. Aoxing is based in China and its US office is located in
Jersey City, NJ.
Source:
Aoxing Pharmaceuticals, OxBridge
Research, Daily
Stock Deals, OTC
King. PSM
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Disclosure/Disclaimer:-
OxBridge Research publishes sponsored research reports, advertorials
and corporate profiles on its portal and several other
websites/blogs, including this website/blog, owned and operated by
OxBridge and/or its affiliates. OxBridge Research is not a Broker
Dealer or a Registered Financial Adviser in any jurisdiction,
whatsoever. All the information published on its website(s) and/or
distributed to its members via various electronic means is for
general awareness and entertainment purpose only. OxBridge urges
investors to do their own due diligence and consult with their
financial adviser prior to making any investment decision. We are
expecting a payment from the company/a third party/shareholder. We
receive compensation from companies for providing various IR
services, including publication, advertisement,and social media
awareness, therefore our views/opinion are inherently biased. Please
read the full disclosure/disclaimer, if you need assistance contact
Editor@OxBridgeResearch.com
OxbridgeResearch.com,
All Rights Reserved. Trademarks/logos are of their respective owners.
It's
YOUR
money - Invest WISELY
TM
